Skip to main content
DYN filings

Corporate insider profile

Johanna Friedl-Naderer Filing Activity

Latest reported as Chief Commercial Officer of Dyne Therapeutics, Inc. (DYN).

Purchase filings
0
Reported companies
1
Net open-market value
-$12,783.21
Latest transaction
Aug 13, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 13, 2026Dyne Therapeutics, Inc. (DYN)Chief Commercial OfficerSale226$26.28$5,939
Jun 16, 2026Dyne Therapeutics, Inc. (DYN)Chief Commercial OfficerSale145$18.33$2,658
May 13, 2026Dyne Therapeutics, Inc. (DYN)Chief Commercial OfficerSale228$18.36$4,186